ROYALTY PHARMA PLC's ticker is RPRX and the CUSIP is G7709Q104. A total of 317 filers reported holding ROYALTY PHARMA PLC in Q3 2022. The put-call ratio across all filers is 0.29 and the average weighting 0.6%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $5,938,748 | -13.1% | 218,819 | -1.5% | 0.00% | 0.0% |
| Q2 2023 | $6,830,520 | -35.0% | 222,203 | -23.8% | 0.00% | -40.0% |
| Q1 2023 | $10,502,961 | +66.0% | 291,506 | +82.1% | 0.01% | +66.7% |
| Q4 2022 | $6,326,243 | -51.7% | 160,077 | -50.9% | 0.00% | -50.0% |
| Q3 2022 | $13,109,000 | -19.4% | 326,259 | -15.7% | 0.01% | -14.3% |
| Q2 2022 | $16,272,000 | +29.4% | 387,059 | +19.9% | 0.01% | +40.0% |
| Q1 2022 | $12,572,000 | +101.5% | 322,699 | +106.1% | 0.01% | +150.0% |
| Q4 2021 | $6,239,000 | +8.0% | 156,570 | -2.1% | 0.00% | 0.0% |
| Q3 2021 | $5,778,000 | -11.2% | 159,879 | +0.7% | 0.00% | -33.3% |
| Q2 2021 | $6,510,000 | +60.3% | 158,809 | +70.6% | 0.00% | +50.0% |
| Q1 2021 | $4,060,000 | +61.7% | 93,087 | +85.5% | 0.00% | +100.0% |
| Q4 2020 | $2,511,000 | +46.6% | 50,172 | +23.2% | 0.00% | 0.0% |
| Q3 2020 | $1,713,000 | – | 40,712 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Siguler Guff Advisers, LLC | 3,391,754 | $92,052,204 | 47.04% |
| Indie Asset Partners, LLC | 433,000 | $11,751,620 | 11.84% |
| SUVRETTA CAPITAL MANAGEMENT, LLC | 4,095,745 | $111,158,519 | 6.01% |
| Advanced Portfolio Management, LLC | 230,000 | $6,242,200 | 5.25% |
| Compound Global Advisors, LLC | 626,412 | $17,000,822 | 3.73% |
| Geo Capital Gestora de Recursos Ltd | 135,079 | $3,666 | 3.39% |
| TORRAY INVESTMENT PARTNERS LLC | 412,633 | $11,198,860 | 1.98% |
| Overbrook Management Corp | 298,712 | $8,107,044 | 1.89% |
| Silicon Valley Community Foundation | 358,270 | $9,723,448 | 1.18% |
| Greytown Advisors Inc. | 74,601 | $2,024,671 | 1.12% |